Evidence map›Paper›PMID 29581763›Full record

ArticleJournal of Cancer2018

Cancer survival in patients from a hospital-based cancer registry, China.

Jian-Guo Chen, Hai-Zhen Chen, Jian Zhu, Yan-Lei Yang, Yong-Hui Zhang, Pei-Xin Huang, Yong-Sheng Chen, Chao-Yong Zhu, Li-Ping Yang, Kang Shen and 2 more

Abstract read
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Iranian journal of biotechnology · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jian-Guo ChenNantong University Tumor Hospital / Institute, 226361 Nantong, China.
Hai-Zhen ChenNantong University Tumor Hospital / Institute, 226361 Nantong, China.
Jian ZhuQidong Liver Cancer Institute, 226200 Qidong, China.
Yan-Lei YangHaimen City Center for Disease Control and Prevention, 226100 Haimen, China.
Yong-Hui ZhangQidong Liver Cancer Institute, 226200 Qidong, China.
Pei-Xin HuangHaimen City Center for Disease Control and Prevention, 226100 Haimen, China.
Yong-Sheng ChenQidong Liver Cancer Institute, 226200 Qidong, China.
Chao-Yong ZhuNantong University Tumor Hospital / Institute, 226361 Nantong, China.
Li-Ping YangNantong University Tumor Hospital / Institute, 226361 Nantong, China.
Kang ShenNantong University Tumor Hospital / Institute, 226361 Nantong, China.
Fu-Lin QiangNantong University Tumor Hospital / Institute, 226361 Nantong, China.
Gao-Ren WangNantong University Tumor Hospital / Institute, 226361 Nantong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer registration (hospital-based)follow-up, survival (life-table method)Neoplasms

Identifiers

PMID29581763
PMCPMC5868149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.